Sanofi (EPA:SAN)
104.12
+0.54 (0.52%)
Feb 21, 2025, 5:38 PM CET
Sanofi Revenue
In the year 2024, Sanofi had annual revenue of 44.29B EUR with 7.73% growth. Sanofi had revenue of 11.42B in the quarter ending December 31, 2024.
Revenue
44.29B
Revenue Growth
+7.73%
P/S Ratio
2.94
Revenue / Employee
534.35K
Employees
82,878
Market Cap
130.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 26.51B |
Sartorius Stedim Biotech | 2.78B |
bioMérieux | 3.81B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.34B |
emeis Société anonyme | 5.43B |
Ramsay Générale de Santé | 5.01B |
Sanofi News
- 10 hours ago - Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's disease - GlobeNewsWire
- 1 day ago - Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector - Business Upturn
- 1 day ago - Chronic Spontaneous Urticaria Market to Register Incremental Growth During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight - Benzinga
- 3 days ago - Sanofi: OpenAI's Research Agents Could Lead To Explosive Growth - Seeking Alpha
- 3 days ago - Sanofi to sell 50% stake in consumer health unit to CD&R - Seeking Alpha
- 3 days ago - Press Release: Sanofi and CD&R sign Opella share purchase agreement - GlobeNewsWire
- 4 days ago - Regeneron, Sanofi asthma therapy Dupixent under FDA review for rare skin condition - Seeking Alpha
- 7 days ago - Sanofi gets FDA approval for NovoLog insulin biosimilar - Seeking Alpha